Phage therapy is an emerging treatment for Crohn's disease, focusing on restoring balance to the gut microbiota. This method targets and eliminates specific pathogenic bacteria, potentially reducing gastrointestinal inflammation without affecting beneficial bacteria. Although still in early stages, with most research conducted on animal models, Georgian clinicians are at the forefront, applying phage therapy in clinical settings to manage Crohn's symptoms effectively.

Phage therapy is increasingly recognized as a viable treatment option for osteomyelitis, a challenging bone infection often caused by bacteria resistant to conventional antibiotics. This innovative approach utilizes bacteriophages to target and eliminate the specific bacteria responsible for the infection, potentially reducing the need for prolonged antibiotic use and its associated side effects. By directly attacking the bacteria, phage therapy can facilitate better recovery outcomes, decrease the likelihood of chronic infection, and promote bone healing, making it a promising adjunct or alternative to traditional treatment methods for osteomyelitis.

Phage therapy shows promise in aiding autistic individuals by targeting gut bacteria associated with symptoms. Experience shows it improves gastrointestinal health and behavior, offering hope for effective intervention.